alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information 
extracted from the financial statements contained in 
the body of the accompanying Form 10-Q of MUZAK 
LIMITED PARTNERSHIP and is qualified in its entirety by 
reference to such financial statements.
</LEGEND>
<CIK> 0000891983
<NAME> MUZAK LIMITED PARTNERSHIP
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          20,313
<SECURITIES>                                         0
<RECEIVABLES>                                   15,483
<ALLOWANCES>                                       526
<INVENTORY>                                      3,617
<CURRENT-ASSETS>                                40,623
<PP&E>                                          72,110
<DEPRECIATION>                                  34,701
<TOTAL-ASSETS>                                 110,843
<CURRENT-LIABILITIES>                           18,217
<BONDS>                                        100,817
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   110,843
<SALES>                                          6,977
<TOTAL-REVENUES>                                43,865
<CGS>                                            4,996
<TOTAL-COSTS>                                   18,587
<OTHER-EXPENSES>                                27,362
<LOSS-PROVISION>                                   181
<INTEREST-EXPENSE>                               5,375
<INCOME-PRETAX>                                (6,988)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,988)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,988)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        


</TABLE>
rytm_Ex10_1


		
			Exhibit 10.1
		

		
			Summary of Non-Employee Director Compensation Policy
		

		
			 
		

		
			Under the Company’s non-employee director compensation policy, all non-employee directors will be paid an annual retainer fee of $40,000 and such additional fees as are set forth in the following table. All payments will be made quarterly in arrears.
		

		
			 
		

			
					
						Non-Employee Director

					
					
						 

					
					
						Annual Fee

					
					
						 

				
	
					
						Lead Director

					
					
						 

					
					
						$

					
25,000
					
					
						 

				
	
					
						Non-Executive Chair

					
					
						 

					
					
						$

					
30,000
					
					
						 

				
	
					
						Chairman of the audit committee

					
					
						 

					
					
						$

					
15,000
					
					
						 

				
	
					
						Member of the audit committee (other than chairman)

					
					
						 

					
					
						$

					
7,500
					
					
						 

				
	
					
						Chairman of the compensation committee

					
					
						 

					
					
						$

					
12,000
					
					
						 

				
	
					
						Member of the compensation committee (other than chairman)

					
					
						 

					
					
						$

					
6,000
					
					
						 

				
	
					
						Chairman of the governance and nominating committee

					
					
						 

					
					
						$

					
8,000
					
					
						 

				
	
					
						Member of the governance and nominating committee (other than chairman)

					
					
						 

					
					
						$

					
4,000
					
					
						 

				



		
			 
		

		
			Under the policy, each individual who is initially appointed or elected to the board of directors will be eligible to receive an option to purchase up to 37,000 shares of our common stock under the 2017 Equity Incentive Plan on the date he or she first becomes a non-employee director. These option grants will vest annually over a three-year period from the date of grant, subject to continued service as a non-employee director through that vesting date. In addition, on the date of the annual meeting of stockholders, each continuing non-employee director who has served on the board of directors for a minimum of six months will be eligible to receive an option grant to purchase up to 18,500 shares of our common stock, which will vest in full upon the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders. The exercise price for each of these option grants will be equal to the fair market value of our common stock on the date of grant. These new director grants and annual grants will be subject to approval by our board of directors at the time of grant. The share numbers set forth herein will be appropriately adjusted for any split or recapitalization of the Company’s securities.
EXHIBIT 23.1 

**INDEPENDENT AUDITORS’ CONSENT**

 

We consent to theincorporation by reference in Registration Statement Nos. 333-92495, 333-92497, 333-92499, 333-75610, and 333-81410 of Huttig Building Products, Inc. on Form S-8 of our report dated February 13, 2004 (which report expresses an unqualified opinionand includes an explanatory paragraph relating to the change in method of accounting for goodwill to conform to Statement of Financial Accounting Standard No. 142, *Goodwill and Other Intangible Assets*effective January 1, 2002 discussed inNote 2 and an explanatory paragraph relating to the restatement of the consolidated balance sheet as of December 31, 2002 discussed in Note 5), appearing in this Annual Report on Form 10-K of Huttig Building Products, Inc. for the year endedDecember 31, 2003. 

 

/s/ Deloitte & Touche LLP 

 

St. Louis, Missouri 

March 9, 2004
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




     In connection with the Quarterly Report of Berkeley  Technology  Limited on
Form 10-Q for the period  ended June 30, 2006 as filed with the U.S.  Securities
and Exchange  Commission  (the  "Report"),  I, Arthur I.  Trueger,  as Executive
Chairman of the registrant,  certify, pursuant to 18 U.S.C. ss. 1350, as adopted
by ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934, and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the registrant.



Date:  August 11, 2006                           By:    /s/  Arthur I. Trueger

                                                        Arthur I. Trueger
                                                        Executive Chairman
Exhibit 31.2

CERTIFICATION

I,
J. Kimo Esplin, certify that:

1.     I
have reviewed this annual report on Form 10-K of Huntsman International Holdings LLC for the year ended December 31, 2003;

2.     Based
on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of and for the periods presented in this report;

4.     The
registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and have:



5.     The
registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):



Date:
March 30, 2004

| |  | /s/J. KIMO ESPLINJ. Kimo Esplin Chief Financial Officer
| |  | -------------------------------------------------------

QuickLinks
EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13a-14a/ 15d-14a
I, Henry Linsert, Jr., certify that:
1. I have reviewed this quarterly report on Form 10-Q of Martek BiosciencesCorporation;
2. Based on my knowledge, this quarterly report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the periods covered by this quarterlyreport;
3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this quarterly report;
4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrantand have:
 a) designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known tous by others within those entities, particularly during the periodsin which this quarterly report is being prepared;  b) evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, asof the end of the period covered by this report based on suchevaluations; and  c) disclosed in this quarterly report any change in theregistrant’s internal control over financial reporting that occurredduring the registrant’s most recent fiscal quarter that hasmaterially affected, or is reasonably likely to materially affect,the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based onour most recent evaluation of internal controls over financial reporting,to the registrant’s auditors and the audit committee of the registrant’sboard of directors (or persons performing the equivalent functions):
 a) all significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financialinformation; and  b) any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’sinternal control over financial reporting.
Date: September 14, 2004
/s/ Henry Linsert, Jr.
Henry Linsert, Jr.
(logo) CWCapital

ASSET MANAGEMENT

 

 

**Annual Statement as toCompliance**

**For the Period of January1, 2016 to December 31, 2016**

 

 

WFRBS 2014-C22

 

 

In accordance with Item 1123of Regulation AB and with the requirements detailed in §11.12 of the Poolingand Servicing Agreement (the “Agreement”) for the above-mentionedCMBS pool, (the “CMBS Pool”), CWCapital Asset Management LLC(“CWCAM”), in its capacity as Special Servicer, is providing thisOfficer’s Certificate with respect to the following:

 

(A) a review of CWCAM’sactivities during the preceding calendar year or portion thereof (the“Reporting Period”) and of CWCAM’s performance under theAgreement has been made under such officer’s supervision and;

 

(B) to the best of suchofficer’s knowledge, based on such review, CWCAM has fulfilled all itsobligations under the Agreement in all material respects throughout theReporting Period.

 

 

Should you have any questions,please do not hesitate to contact us. Sincerely,

CWCapital Asset Management LLC

  

 

/s/David B. Iannarone 

David B. Iannarone 

President 

 

 

7501 Wisconsin Avenue, Suite500 West, Bethesda, MD 20814

www.cwcapital.com
No. 87-6398.

#### Lipsey *v.*Federal Deposit Insurance Corporation et al.

App. Ct. Ill., 1st Dist. Certiorari denied.
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano 

Richard H. Bernstein

Joan L. Larsen, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 October 23, 2015

t1020

Order 

Clerk

October 23, 2015

150610 

THOMAS TIBBLE, Bankruptcy Trustee for the

BANKRUPTCY ESTATE OF ROBERT

PRODINGER, D.O., and STEPHEN L.

LANGELAND, Bankruptcy Trustee for the

BANKRUPTCY ESTATE OF BATTLE 

CREEK EMERGENCY PHYSICIANS, P.C.,

Plaintiffs-Appellants,

and

DALE RUSSELL, P.C.,

Plaintiff,

v SC: 150610

COA: 306964

Calhoun CC: 2006-001805-CZ

AMERICAN PHYSICIANS CAPITAL INC.,

Defendant-Appellee.

_________________________________________/

On order of the Chief Justice, a stipulation signed by counsel for the parties 

agreeing to the dismissal of this application for leave to appeal is considered, and the 

application for leave to appeal is DISMISSED with prejudice and without costs.
# CADRE Rover Getting Prepped for Testing

An engineer prepares a small rover – part of NASA's CADRE (Cooperative Autonomous Distributed Robotic Exploration) technology demonstration that's headed to the Moon – for testing in a thermal vacuum chamber at the agency's Jet Propulsion Laboratory in Southern California in October 2023.

Read More

                    -  Facebook PinterestX
-  LinkedIn Emailhttps://www.nasa.gov/image-detail/pia25669orig/Copy URL to clipboard>DownloadShareTakenOctober 24, 2013Image CreditNASA/JPL-CaltechSize8272x6200pxNational Aeronautics and Space Administration
NASA explores the unknown in air and space, innovates for the benefit of humanity, and inspires the world through discovery.
- About NASA's Mission
Join Us- Home
- News & Events
- Multimedia
- NASA+
- Missions
- Humans in Space
- Earth & Climate
- The Solar System
- The Universe
- Science
- Aeronautics
- Technology
- Learning Resources
- About NASA
- NASA en Español
Follow NASA-   
-   
-   
-   
- More NASA Social Accounts
- NASA Newsletters
- Sitemap
- For Media
- Privacy Policy
- FOIA
- No FEAR Act
- Office of the IGBudget & Annual Reports
Agency Financial Reports
Contact NASA
Accessibility
-  									Page Last Updated:								  								Oct 25, 2023								 
-  									Page Editor:								  									Monika Luabeya								 
-  								Responsible NASA Official:							  								Abigail Bowman
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 07-6751
UNITED STATES OF AMERICA, Plaintiff - Appellee, versus JOELL A. LEWIS, Defendant - Appellant. Appeal from the United States District Court for the Western District of North Carolina, at Charlotte. Frank D. Whitney, District Judge. (3:03-cr-00151-3; 3:07-cv-00099) Submitted: September 13, 2007 Decided: September 19, 2007 Before GREGORY and DUNCAN, Circuit Judges, and WILKINS, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Joell A. Lewis, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit.- 2 - PER CURIAM: Joell A. Lewis seeks to appeal the district court’s order denying relief on his 28 U.S.C. § 2255 (2000) motion. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by demonstrating that reasonable jurists would find that any assessment of the constitutional claims by the district court is debatable or wrong and that any dispositive procedural ruling by the district court is likewise debatable. Miller-El v. Cockrell , 537 U.S. 322, 336-38 (2003); Slack v. McDaniel , 529 U.S. 473, 484 (2000); Rose v. Lee , 252 F.3d 676, 683-84 (4th Cir. 2001). We have independently reviewed the record and conclude that Lewis has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
#### Ramsay and Another *v.*Herndon.

The declaration in a suit by *Cunningham Ramsay*and *John Fattier*on a promissory note, described the note as payable to the plaintiffs by the name of *Ramsay*and *Fattier. Held,*that a note, payable on its face to *Ramsay*and *Fattier,*was not objectionable as evidence on the ground of variance. *Held,*also, that had the words in the declaration, “ by the name of *Ramsay*and Fattier,” been omitted, there would still have been no variance as to the names of the payees. *Held,*also, that the plaintiffs’ possession of the note was sufficient evidence, *prima facie,*that they were the persons to whom the note was payable.

An indorsement on a note by the payees to themselves is a nullity.

*Monday, June*8.

ERROR to the *Tippecanoe*Circuit Court.

Blackford, J.

This was an action of assumpsit, brought in 1836 by *Cunningham Ramsay*and *John Vattier*against the defendant, on a promissory note. The declaration states *346that the note is payable to the plaintiffs by the name of *Ramsay*and *Vattier;*that the payees, by the name of *Ramsay*and Vattier, assigned the note to the plaintiffs; that the note is unpaid, &c. Plea, non assumpsit. The plaintiffs, on the trial, offered in evidence a note executed by the defendant, and payable, on its face, to *Ramsay*and *Vattier.*It was indorsed by the name of *Ramsay*and *Vattier*to the plaintiffs; and it agreed as to date, sum, &c. with the note described in the declaration. The defendant objected to the note as evidence, and the objection was sustained. Verdict and judgment, at the *November*term, 1838, for the defendant.

The statement in the declaration as to the assignment of the note by the payees to themselves, is mere surplusage.

The plaintiffs must be considered as suing in the character of payees, and averring that the note is payable to them by the names of *Ramsay*and *Vattier.*

There is no variance, therefore, as. to the names of the payees, between the note offered in evidence and that described in the declaration. Indeed, had the words in the declaration, “by the name of *Ramsay*and Vattier,” been omitted, there would still have been, no variance as to the names of the payees, as *Ramsay*and *Vattier*are the surnames of the plaintiffs.

The indorsement on the note by the payees to themselves is a nullity.

We are of opinion further, that the plaintiffs’ possession of this note, payable as shown by its face to *Ramsay*and *Vat-tier,*is sufficient evidence, *prima facie,*that the plaintiffs' are the persons to .whom the note is payable. *Taylor*v. *Coquillard, May*term, 1839.

The case now before us is distinguishable from that .of *Fraser*v. *Spofford et al., Nov.*term, 1839. In that case, there was nothing on the face of the note tending to show that *Kimball,*one of the plaintiffs, was one of the payees of the note.

*Per Curiam.*

The judgment is reversed, and the proceedings subsequent to the verdict inclusive set aside, with costs. Cause remanded, &c.

*347*A. Ingram*and *C. B.*Smith, for the plaintiffs.

*S. C. Willson, II. S. Lane, T. A. Howard,*and *W. P. Bryant,*for the defendant.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information
extracted from the financial statements contained in
the body of the accompanying Form 10-Q of MUZAK
LIMITED PARTNERSHIP and is qualified in its entirety
by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<CIK> 0000891983
<NAME> MUZAK LIMITED PARTNERSHIP
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                          24,632
<SECURITIES>                                         0
<RECEIVABLES>                                   15,158
<ALLOWANCES>                                       496
<INVENTORY>                                      3,408
<CURRENT-ASSETS>                                44,725
<PP&E>                                          69,944
<DEPRECIATION>                                  32,539
<TOTAL-ASSETS>                                 115,921
<CURRENT-LIABILITIES>                           18,801
<BONDS>                                        100,497
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   115,921
<SALES>                                          5,150
<TOTAL-REVENUES>                                21,793
<CGS>                                            2,503
<TOTAL-COSTS>                                    9,178
<OTHER-EXPENSES>                                13,196
<LOSS-PROVISION>                                    50
<INTEREST-EXPENSE>                               2,695
<INCOME-PRETAX>                                (3,166)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (3,166)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,166)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        


</TABLE>
NO. SCPW-12-0000021
IN THE SUPREME COURT OF THE STATE OF HAWAI # I
WAYNE M. SAKAI and SAKAI IWANAGA SUTTON LAW GROUP, Petitioners,

vs. THE HONORABLE RANDAL G.B VALENCIANO, JUDGE OF THE CIRCUIT COURT OF THE FIFTH CIRCUIT, STATE OF HAWAI # I and DTRIC INSURANCE COMPANY LIMITED, Respondents.

ORIGINAL PROCEEDING (CIVIL NO. 11-1-0076)
ORDER GRANTING PETITION FOR WRIT OF MANDAMUS (By: Recktenwald, C.J., Nakayama, Duffy, and McKenna, JJ. and Circuit Judge Chan, in place of Acoba, J., recused) Upon consideration of petitioners Wayne M. Sakai and Sakai Iwanaga Sutton Law Group's petition for a writ of mandamus and the responses thereto, it appears that: (1) Cades Schutte, as a result of its representation of petitioners, obtained confidential information of a non-public nature that, if known to any other client of Cades Schutte, could be used by such client to petitioners' material disadvantage and (2) petitioners' February 28, 2010 prospective conflict waiver did not, by its terms, apply in such instance. Therefore, Electronically Filed Supreme Court SCPW-12-0000021 17-MAY-2012 03:45 PM2 IT IS HEREBY ORDERED that the petition for a writ of mandamus is granted. The respondent judge is directed to: (1) vacate the December 12, 2011 order denying petitioners' motion to disqualify Cades Schutte as plaintiff's counsel in Civil No. 11- 1-0076 and (2) enter an order disqualifying Cades Schutte as plaintiff's counsel in Civil No. 11-1-0076.

DATED: Honolulu, Hawai # i, May 17, 2012. /s/ Mark E. Recktenwald /s/ Paula A. Nakayama /s/ James E. Duffy, Jr. /s/ Sabrina S. McKenna /s/ Derrick H.M. Chan